Abstract
Serum levels of methaqualone (MTQ) were determined in eight unfasted subjects following single- and multiple-dose administration of 1×300 mgtablet over a 28-day period. Data were analyzed by a two-compartment open model. Following a fairly rapid absorptive phase (K a =0.82±0.32 hr−1),the serum elimination curve was biexponential, consisting of a phase predominantly due to distribution (α=0.97±0.55 hr−1)and a phase predominantly due to elimination (β=0.036±0.004 hr−1).A steady-state MTQ serum concentration profile was observed within the first week. There were no significant changes in the kinetics of absorption, distribution, or elimination over the 28-day period of drug administration. Urinary D-glucaric acid excretion, which increased two-to threefold after the first week of MTQ dosing, returned to normal levels when the drug was discontinued. The significance of the pharmacokinetic parameters in relation to bioavailability and biological disposition of single and multiple dose MTQ administration is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
A. H. Amin, D. R. Mehta, and S. S. Samarth. Biological activity in the quinazolone series.Progr. Drug Res. 14: 218–268 (1970).
Methaqualone Bibliography, William H. Rorer, Inc., Fort Washington, Pa.
S. S. Brown and S. Goenechea. Methaqualone: Metabolic, kinetic, and clinical pharmacologic observations.Clin. Pharmacol. Therap. 14: 314–324 (1973).
V. G. Prabhu, S. H. Parikh, and G. F. Shah. Effect of chronic treatment of methaqualone on the turnover of hexobarbital and methaqualone in rats.Indian J. Med. Sci. 21: 524–532 (1967).
R. D. Smyth, J. K. Lee, A. Polk, P. B. Chemburkar, and A. M. Savacool. Bioavailability of methaqualone.J. Clin. Pharmacol. 13: 391–401 (1973).
L. Goldstein, J. Fraedon, D. Willard, F. Goldstein, and R. R. Smith. A comparative study of the effects of methaqualone and glutethimide on sleep in male chronic insomniacs.J. Clin. Pharmacol. 10: 258–268 (1970).
K. Diem (ed.).Documenta Geigy. Scientific Tables, 6th ed., Geigy Pharmaceuticals, Ardsley, N.Y., 1962, p. 624.
S. S. Brown and G. A. Smart. Fluorimetric assay of methaqualone in plasma by reduction to 1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolylquinazoline.J. Pharm. Pharmacol. 21: 466–468 (1969).
M. Mitchard and M. Williams. Improved quantitative GLC assay for estimation of methaqualone in biological fluids.J. Chromatog. 72: 29–34 (1972).
C. A. Marsh. Metabolism ofD-glucuronolactone in mammalian system.Biochem. J. 86: 77–86 (1963).
R. D. Smyth, P. B. Chemburkar, A. Polk, and J. K. Lee. Comparative methaqualone bioavailability.Abst. APhA Acad. Pharm. Sci. 3: 48 (1973).
R. B. Smith, L. W. Dittert, W. O. Griffen, Jr., and J. T. Doluisio. Pharmacokinetics of pentobarbital after oral administration.J. Pharmacokinet. Biopharm. 1: 5–16 (1973).
J. G. Wagner.Biopharmaceutics and Relevant Pharmacokinetics, Drug Intelligence Publications, Hamilton Press, Hamilton, Ill., 1971.
C. M. Metzler.A Brief Introduction to Nonlinear Least Squares Estimation, Compilation of symposia papers, APhA Academy of Pharmaceutical Sciences, 1970, p. 380.
R. N. Morris, G. A. Gunderson, S. W. Babcock, and J. F. Zaroslinski. Plasma levels and absorption of methaqualone after oral administration to man.Clin. Pharmacol. Therap. 13: 719–723 (1972).
R. A. Ronfeld and L. Z. Benet. Interpretation of plasma concentration-time curves after oral dosing.Abst. APhA Acad. Pharm. Sci. 1: 53 (1971).
W. L. Way and A. J. Trevor. Sedative-hypnotics.Anesthesiology 34: 170–181 (1971).
R. C. Saxena, N. S. Bhatnagar, S. C. Misra, and K. P. Bhargava. Intravenous methaqualone: A new non-barbiturate anaesthetic.Brit. J. Anaesth. 44: 83–85 (1972).
D. N. Bailey and P. I. Jatlow. Methaqualone overdose: Analytical methodology and the significance of serum drug concentrations.Clin. Chem. 19: 615–620 (1973).
B. Ballinger, K. O'Malley, I. H. Stevenson, and M. J. Turnbull. Stimulation of drug metabolism by centrally active drugs.Brit. J. Pharmacol. 41: 383P (1971).
J. Hunter, J. D. Maxwell, D. A. Stewart, and R. Williams. UrinaryD-glucaric acid excretion and total liver content of cytochrome P-450 in guinea pigs: Relationship during enzyme induction and following inhibition of protein synthesis.Biochem. Pharmacol. 22: 743–747 (1973).
J. Hunter, J. D. Maxwell, D. A. Stewart, R. Williams, J. Robinson, and A. Richardson. Increased hepatic microsomal enzyme activity from occupational exposure to certain organochlorine pesticides.Nature 237: 339–401 (1972).
B. Ballinger, M. Browning, K. O'Malley, and I. H. Stevenson. Drug-metabolizing capacity in states of drug dependence and withdrawal.Brit. J. Pharmacol. 45: 638–643 (1972).
J. Zaroslinski, R. Browne, and L. Possley. Effect of subacute administration of methaqualone and glutethimide on plasma levels of bishydroxycoumarin.Arch. Internat. Pharmacodyn. Therap. 195: 185–191 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nayak, R.K., Smyth, R.D., Chamberlain, J.H. et al. Methaqualone pharmacokinetics after single- and multiple-dose administration in man. Journal of Pharmacokinetics and Biopharmaceutics 2, 107–121 (1974). https://doi.org/10.1007/BF01061503
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01061503